✦ LIBER ✦

CYP2D6 Genotype Should Not Be Used to Determine Endocrine Therapy in Postmenopausal Breast Cancer Patients

✍ Scribed by Rae, J M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

419 Optimizing adjuvant endocrine therap

✍ G.H. Di; Z.M. Shao; K.D. Yu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

CYP2D6 genotype affects outcome in postm

✍ AM Thompson, S Bray, AM Johnson, P Quinlan, DM Nikloff, DG Evans… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 390 KB

CYP2D6 Genotype and Tamoxifen Response i

✍ Regan, M. M.; Leyland-Jones, B.; Bouzyk, M.; Pagani, O.; Tang, W.; Kammler, R.; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 529 KB

374 Patient-reported outcomes in breast

✍ M. Hubalek 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

CYP2D6 genotyping and use of antidepress

✍ van der Merwe, Nicole; Bouwens, Christianne S. H.; Pienaar, Rika; van der Merwe, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 159 KB

Erratum to: The use of the13C-dextrometh

✍ Opdam, F. L.; Dezentje, V. O.; Hartigh, J.; Modak, A. S.; Vree, R.; Batman, E.; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 108 KB